Surgery Partners Inc. (NASDAQ:SGRY) was down 2.2% during trading on Thursday . The stock traded as low as $15.94 and last traded at $16.47, with a volume of 95,408 shares. The stock had previously closed at $16.84.

SGRY has been the subject of a number of analyst reports. Jefferies Group restated a “buy” rating on shares of Surgery Partners in a research report on Wednesday. Barclays PLC initiated coverage on Surgery Partners in a research report on Wednesday, July 13th. They issued an “equal weight” rating and a $20.00 price target for the company. Zacks Investment Research upgraded Surgery Partners from a “sell” rating to a “hold” rating in a research report on Thursday, April 14th. Morgan Stanley restated a “hold” rating on shares of Surgery Partners in a research report on Friday, May 6th. Finally, KeyCorp initiated coverage on Surgery Partners in a research report on Thursday, June 9th. They issued an “overweight” rating and a $21.00 price target for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $22.44.

The firm has a market cap of $841.91 million and a PE ratio of 694.40. The company’s 50-day moving average price is $17.30 and its 200-day moving average price is $15.33.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Tuesday, August 9th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.14 by $0.02. The company had revenue of $289.70 million for the quarter, compared to analyst estimates of $275.99 million. The company’s revenue for the quarter was up 24.4% on a year-over-year basis. On average, equities analysts anticipate that Surgery Partners Inc. will post $0.54 EPS for the current fiscal year.

Other large investors recently bought and sold shares of the company. Wells Fargo & Company MN bought a new stake in Surgery Partners during the fourth quarter worth about $14,025,000. BlackRock Advisors LLC bought a new stake in Surgery Partners during the fourth quarter worth about $23,579,000. Finally, Jennison Associates LLC bought a new stake in Surgery Partners during the fourth quarter worth about $34,117,000.

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.